The CDC announced an expected 3 to 10 month shortage of Aplisol (tuberculin purified protein derivative [PPD], diluted), used as an aid in the diagnosis of tuberculosis.
Compared with standard of care tests and most clinical signs, the molecular bacterial load assay demonstrated higher sensitivity and more rapid turnaround times for monitoring tuberculosis treatment.
Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with pneumonia and patients with an acute IPF exacerbation.
Guidelines have been updated for screening and treatment for tuberculosis infection among health care personnel.
Oral voriconazole may be more effective than oral itraconazole for initial maintenance therapy in patients with chronic pulmonary aspergillosis, according to a study published in Clinical Infectious Diseases.1 Currently, there are 4 oral anti-Aspergillus agents available (itraconazole, voriconazole, posaconazole, and isavuconazole) and while various studies have evaluated treatments for chronic pulmonary aspergillosis with itraconazole and…
Prospective surveillance of enterovirus D68 is contributing to a better understanding of its epidemiology and should be continued.
The incidence of tuberculosis in the United States in 2018 was 2.8 cases per 100,000 persons, which is the lowest ever reported.
Scale identifies college students at increased risk for corticosteroid Rx, chronic fatigue syndrome
An internet-based training program designed to enhance communication skills in C-reactive protein point of care testing may be helpful in reducing long-term antibiotic prescribing in respiratory tract infections.
Faster progression to end-stage lung disease observed among patients with CMV IgG positivity
The new interferon-gamma release assay QuantiFERON-TB Gold Plus had good sensitivity in children with pulmonary tuberculosis.
The first-ever UN High-Level Meeting on tuberculosis, in September 2018, resolved that ending the disease is a global priority.
Nasopharyngeal microbiota seem to serve as a valid proxy for lower respiratory tract microbiota in lower respiratory tract infections in children.
More than one in five infants with a bronchiolitis hospital admission will have a subsequent respiratory-related hospital admission by age 5 years.
SynGEM, an intranasal subunit vaccine that introduces the respiratory syncytial virus (RSV), has demonstrated efficacy in actuating lasting immune responses in humans.
In a subgroup of patients with multidrug-resistant tuberculosis, vitamin D supplementation accelerated sputum culture conversion.
Chronic pulmonary aspergillosis complicates treated pulmonary tuberculosis frequently.
Investigators sought to confirm long-standing hypotheses that acute infections can lead to myocardial infarction.
Treatment for invasive aspergillosis using diagnostic-driven approach of voriconazole, galactomannan testing led to better outcomes than empiric therapy.
A freeze-dried, temperature-stable, experimental tuberculosis vaccine candidate has entered a phase 1 human clinical trial.